The widespread usage of antibiotics in human and veterinary medicine is leading to more and more antibiotic-resistant microorganisms. It has been projected that by 2050 more people will die from antibiotic resistance than from cancer.
Novel antibiotics are direly needed, but the traditional method for efficacy testing promising compounds – the plate count – is laborious, cumbersome, and slow. For many bacterial species it is necessary to wait for more than five days before colonies can be counted. The plate count method therefore represents a severe bottleneck in the development of novel antimicrobials.
BactoBox employs a new approach to bacteria measurements called impedance flow cytometry. Inside a microfluidic flow-cell, bacteria in the sample are detected and distinguished from particles and killed cells based on their electrical properties. It differs from existing technologies by combining affordable with fast, accurate and easy-to-use. BactoBox can provide the answer within one to three minutes with no need for OD/CFU calibration curves so you can move swiftly to the actual experiment and speed up your antimicrobial R&D.
If you are interested in learning more about the benefits of BactoBox – please reach out to us via email to [email protected]
© Text source: https://www.bbc.com/news/health-30416844 - Superbugs to kill 'more than cancer' by 2050
SBT Instruments © 2021
SBT Instruments © 2020